COMBINED THERAPY FOR THYROID SQUAMOUS CELL CARCINOMA

Filip Vos, A. Sewnaik, JHW (Johannes) de Wilt, EJ (Ernst) Smid, Michael den Bakker, Esther van Meerten

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

Background. Squamous carcinoma of the thyroid is a rare aggressive disease, resulting in poor prognosis. Methods and Results. We combined cisplatin with paclitaxel on a weekly basis as induction therapy, achieving a high cumulative dose, in a patient with squamous cell tumor of the thyroid with arterial encasement. After surgery, pathologic examination confirmed a complete resection of the primary tumor with clear margins, revealing a successful induction treatment with chemotherapy. Conclusions. Our patient now has a recurrence-free survival of >20 months, longer than the mean survival described in the literature. (C) 2010 Wiley Periodicals, Inc. Head Neck 34: 131-134, 2012
Original languageUndefined/Unknown
Pages (from-to)131-134
Number of pages4
JournalHead & Neck-Journal for the Sciences and Specialties of the Head and Neck
Volume34
Issue number1
DOIs
Publication statusPublished - 2012

Cite this